Galapagos And University Of Bristol Enter Drug Discovery Collaboration In Chronic Pain

Galapagos NV (Euronext: GLPG) and the University of Bristol announced a new drug discovery collaboration aimed at developing treatments for chronic pain associated with diabetes (diabetic neuropathic pain). Galapagos' service division BioFocus will provide hit-to-lead and lead optimization services for a Wellcome Trust funded program at the University of...

Genesis Spine Associates Offers New Therapy For Diabetic Neuropathy

Genesis Spine Associates now offers Infrared Relief - a new, highly effective pain management therapy using infrared light for patients suffering from diabetic neuropathies. This new therapy offers a simple, painless option for managing patients' pain without potentially dangerous drugs or...

Study Examines Costs Of Neuropathic Pain

Constantly rising U.S. health care costs could be reduced significantly by preventing and treating neuropathic pain conditions associated with diabetes and herpes zoster virus infections, according to research published in The Journal of Pain, the peer review publication of the American Pain Society, http://www.ampainsoc.org and...